# Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting.

> **NCT00351390** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 152 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **OTHER:** Drug therapy for HF
- **OTHER:** NT-proBNP guided HF therapy

## Key facts

- **NCT ID:** NCT00351390
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2019-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351390, "Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00351390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*